日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of a PD-1/CD28 chimeric switch receptor to augment CAR-T function in dogs with spontaneous B cell lymphoma

验证PD-1/CD28嵌合转换受体在自发性B细胞淋巴瘤犬中增强CAR-T细胞功能的作用

Sho Yoshimoto ,Ayano Kudo ,Antonia Rotolo ,Kay Foos ,Lauren Olenick ,Satoshi Takagi ,Nicola J Mason

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

通过 CD28/CD40 嵌合共刺激抗原受体 (CoStAR™) 发出信号,靶向叶酸受体 α,增强 T 细胞活性并增强肿瘤浸润淋巴细胞的肿瘤反应性

Milena Kalaitsidou, Owen R Moon, Martina Sykorova, Leyuan Bao, Yun Qu, Sujita Sukumaran, Michael Valentine, Xingliang Zhou, Veethika Pandey, Kay Foos, Sergey Medvedev, Daniel J Powell Jr, Akshata Udyavar, Eric Gschweng, Ruben Rodriguez, Mark E Dudley, Robert E Hawkins, Gray Kueberuwa, John S Bridgem

Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer

胰岛素样生长因子 2 受体和雄激素作为三阴性乳腺癌的治疗靶点

Nalo Hamilton, David Austin, Diana Márquez-Garbán, Rudy Sanchez, Brittney Chau, Kay Foos, Yanyuan Wu, Jaydutt Vadgama, Richard Pietras